Literature DB >> 26912443

Interventional Molecular Imaging.

Stephen B Solomon1, Francois Cornelis2.   

Abstract

Although molecular imaging has had a dramatic impact on diagnostic imaging, it has only recently begun to be integrated into interventional procedures. Its significant impact is attributed to its ability to provide noninvasive, physiologic information that supplements conventional morphologic imaging. The four major interventional opportunities for molecular imaging are, first, to provide guidance to localize a target; second, to provide tissue analysis to confirm that the target has been reached; third, to provide in-room, posttherapy assessment; and fourth, to deliver targeted therapeutics. With improved understanding and application of(18)F-FDG, as well as the addition of new molecular probes beyond(18)F-FDG, the future holds significant promise for the expansion of molecular imaging into the realm of interventional procedures.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  PET/CT; ablation; biopsy; cancer; fluorescence imaging; interventional oncology; interventional radiology; molecular imaging

Mesh:

Substances:

Year:  2016        PMID: 26912443      PMCID: PMC5484794          DOI: 10.2967/jnumed.115.161190

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  32 in total

1.  Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.

Authors:  Helmut Schoellnast; Steven M Larson; Sadek A Nehmeh; Jorge A Carrasquillo; Raymond H Thornton; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2010-05-28       Impact factor: 2.740

2.  Comparison of CT-guided percutaneous biopsy with and without registration of prior PET/CT images to diagnose mediastinal tumors.

Authors:  Koichi Yokoyama; Osamu Ikeda; Koichi Kawanaka; Yutaka Nakasone; Yoshitaka Tamura; Seijiro Inoue; Fumi Sakamoto; Morikatsu Yoshida; Shinya Shiraishi; Yasuyuki Yamashita
Journal:  Cardiovasc Intervent Radiol       Date:  2013-11-22       Impact factor: 2.740

3.  A pilot study imaging integrin αvβ3 with RGD PET/CT in suspected lung cancer patients.

Authors:  Song Gao; Honghu Wu; Wenwu Li; Shuqiang Zhao; Xuepeng Teng; Hong Lu; Xudong Hu; Suzhen Wang; Jinming Yu; Shuanghu Yuan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-09       Impact factor: 9.236

4.  A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer.

Authors:  Neeta Pandit-Taskar; Joseph A O'Donoghue; Jeremy C Durack; Serge K Lyashchenko; Sarah M Cheal; Volkan Beylergil; Robert A Lefkowitz; Jorge A Carrasquillo; Danny F Martinez; Alex Mak Fung; Stephen B Solomon; Mithat Gönen; Glenn Heller; Massimo Loda; David M Nanus; Scott T Tagawa; Jarett L Feldman; Joseph R Osborne; Jason S Lewis; Victor E Reuter; Wolfgang A Weber; Neil H Bander; Howard I Scher; Steven M Larson; Michael J Morris
Journal:  Clin Cancer Res       Date:  2015-07-14       Impact factor: 12.531

5.  Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT.

Authors:  Steven P Rowe; Michael A Gorin; Hans J Hammers; M Som Javadi; Hazem Hawasli; Zsolt Szabo; Steve Y Cho; Martin G Pomper; Mohamad E Allaf
Journal:  Ann Nucl Med       Date:  2015-08-19       Impact factor: 2.668

Review 6.  [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.

Authors:  Morsal Samim; Ghassan E El-Haddad; Izaak Quintes Molenaar; Warner Prevoo; Maurice A A J van den Bosch; Abass Alavi; Marnix G E H Lam
Journal:  PET Clin       Date:  2014-08-12

7.  Performance of intra-procedural 18-fluorodeoxyglucose PET/CT-guided biopsies for lesions suspected of malignancy but poorly visualized with other modalities.

Authors:  F Cornelis; M Silk; H Schoder; H Takaki; J C Durack; J P Erinjeri; C T Sofocleous; R H Siegelbaum; M Maybody; S B Solomon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-09       Impact factor: 9.236

Review 8.  Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.

Authors:  Lucas Goense; Peter S N van Rossum; Johannes B Reitsma; Marnix G E H Lam; Gert J Meijer; Marco van Vulpen; Jelle P Ruurda; Richard van Hillegersberg
Journal:  J Nucl Med       Date:  2015-05-07       Impact factor: 10.057

9.  PET/CT-guided interventions: personnel radiation dose.

Authors:  E Ronan Ryan; Raymond Thornton; Constantinos T Sofocleous; Joseph P Erinjeri; Meier Hsu; Brian Quinn; Lawrence T Dauer; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2012-11-15       Impact factor: 2.797

10.  18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and background tissues.

Authors:  Stephen P Povoski; Douglas A Murrey; Sabrina M Smith; Edward W Martin; Nathan C Hall
Journal:  BMC Cancer       Date:  2014-06-19       Impact factor: 4.430

View more
  12 in total

1.  Crossing technological frontiers in radioguided intervention.

Authors:  Renato A Valdés Olmos; Sergi Vidal-Sicart; Fijs Wb van Leeuwen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12       Impact factor: 9.236

2.  Immediate Postablation 18F-FDG Injection and Corresponding SUV Are Surrogate Biomarkers of Local Tumor Progression After Thermal Ablation of Colorectal Carcinoma Liver Metastases.

Authors:  Francois H Cornelis; Elena N Petre; Efsevia Vakiani; David Klimstra; Jeremy C Durack; Mithat Gonen; Joseph Osborne; Stephen B Solomon; Constantinos T Sofocleous
Journal:  J Nucl Med       Date:  2018-02-09       Impact factor: 10.057

3.  Long-Half-Life 89Zr-Labeled Radiotracers Can Guide Percutaneous Biopsy Within the PET/CT Suite Without Reinjection of Radiotracer.

Authors:  Francois H Cornelis; Jeremy C Durack; Neeta Pandit-Taskar; Gary A Ulaner; Jason S Lewis; Michael J Morris; Stephen B Solomon
Journal:  J Nucl Med       Date:  2017-08-17       Impact factor: 10.057

4.  Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study.

Authors:  Leigh C Casadaban; Paul J Catalano; Leslie K Lee; Hyewon Hyun; Kemal Tuncali; Victor H Gerbaudo; Paul B Shyn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-09       Impact factor: 9.236

5.  Effective Prostate-Specific Membrane Antigen-Based 18F-DCFPyL-Guided Cryoablation of a Single Positive Site in a Patient Believed to Be More Metastatic on 11C-Choline PET/CT.

Authors:  Francois H Cornelis; Jeremy C Durack; Michael J Morris; Howard I Scher; Stephen B Solomon
Journal:  Clin Nucl Med       Date:  2017-12       Impact factor: 7.794

6.  A Comparative Study of Ablation Boundary Sharpness After Percutaneous Radiofrequency, Cryo-, Microwave, and Irreversible Electroporation Ablation in Normal Swine Liver and Kidneys.

Authors:  Francois H Cornelis; Jeremy C Durack; Simon Y Kimm; Thomas Wimmer; Jonathan A Coleman; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  Cardiovasc Intervent Radiol       Date:  2017-05-17       Impact factor: 2.740

Review 7.  Treatment of Primary Liver Tumors and Liver Metastases, Part 2: Non-Nuclear Medicine Techniques.

Authors:  Francois H Cornelis; Stephen B Solomon
Journal:  J Nucl Med       Date:  2018-10-25       Impact factor: 10.057

Review 8.  Ergonomics in Interventional Radiology: Awareness Is Mandatory.

Authors:  Francois H Cornelis; Leo Razakamanantsoa; Mohamed Ben Ammar; Raphael Lehrer; Idriss Haffaf; Sanaa El-Mouhadi; Francois Gardavaud; Milan Najdawi; Matthias Barral
Journal:  Medicina (Kaunas)       Date:  2021-05-14       Impact factor: 2.430

9.  [18F]fluoroethyltyrosine-induced Cerenkov Luminescence Improves Image-Guided Surgical Resection of Glioma.

Authors:  David Y Lewis; Richard Mair; Alan Wright; Kieren Allinson; Scott K Lyons; Tom Booth; Julia Jones; Robert Bielik; Dmitry Soloviev; Kevin M Brindle
Journal:  Theranostics       Date:  2018-07-01       Impact factor: 11.556

Review 10.  Recent methodology advances in fluorescence molecular tomography.

Authors:  Yu An; Kun Wang; Jie Tian
Journal:  Vis Comput Ind Biomed Art       Date:  2018-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.